1. M 3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland
2. Effects of YM905, a Novel Muscarinic M3-Receptor Antagonist, on Experimental Models of Bowel Dysfunction In Vivo
3. 3M Kuipers, D Tran, W Krauwinkel, B Abila, and H Mulder . Absolute Bioavailability of YM905 in Healthy Male Volunteers: a Single-Dose, Randomized, Two-Period Crossover Study. Presented at the 32nd International Continence Society Annual Meeting, Heidelberg, Germany, 2002 .
4. 4R Smulders, W Tan H, Krauwinkel, B Abila, and J van Zitjveld . A Placebo-Controlled, Dose-Rising Study in Healthy Male Volunteers to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of YM905. Presented at the 32nd International Continence Society Annual Meeting, Heidelberg, Germany, 2002 .
5. The influence of food on the absorption and metabolism of drugs: an update